Royalty Pharma PLC (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Royalty Pharma plc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Royalty Pharma plc - Ordinary Shares - Class A
Rating: 2.521361
Author: Trendlyne DVM scores

Turnaround Potential

about

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

40.41 -0.33 (-0.81%)

Near 52W High of $41.70

3.2M

XNAS Volume

XNAS 28 Jan, 2026 4:18 PM (EST)

Medium Financial Strength

44.4 / 100

Mid Valuation

46.5 / 100

Technically Moderately Bullish

66.3 / 100

Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM

1Yr Price target upside is 16%

9 analysts

Royalty Pharma PLC (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Royalty Pharma PLC (Class A) Live Stock Price Today, Share Analysis and Chart

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

Near 52W High of $41.70

SWOT Analysis

Royalty Pharma PLC (Class A) Live Price Chart